Long-term cultured human neural stem cells undergo spontaneous transformation to tumor-initiating cells

International Journal of Biological Sciences

Volumn 7, Issue 6, 2011, Pages 892-901

  Wu, Weihua ^a,b   He, Qihua ^a,b   Li, Xiaoxia ^a,b   Zhang, Xiaoyan ^a,b   Lu, Aili ^a,b   Ge, Ruimin ^a,b   Zhen, Hongying ^a,b   Chang, Alfred E ^c   Li, Qiao ^c   Shen, Li ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Epidermal growth factor receptor (EGFR); Malignant transformation; Tumorigenesis; Xenograft

Indexed keywords

MUS; MUS MUSCULUS;

EID: 79961011472     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.7.892     Document Type: Article

References (40)

1. Lendahl U, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell 1990; 60: 585-595.
2. Vescovi AL, Galli R, Reynolds BA. Brain tumour stem cells. Nat Rev Cancer 2006; 6: 425-436.
3. Røsland GV, Svendsen A, Torsvik A, et al. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res. 2009; 69: 5331-5339.
4. Casalbore P, Budoni M, Ricci-Vitiani L, et al. Tumorigenic potential of olfactory bulb-derived human adult neural stem cells associates with activation of TERT and NOTCH1. PLoS One. 2009; 4: e4434.
5. Radtke C, Redeker J, Jokuszies A, et al. In vivo transformation of neural stem cells following transplantation in the injured nervous system. J Reconstr Microsurg. 2010; 26: 211-212.
6. Siebzehnrubl FA, Jeske I, Müller D, et al. Spontaneous in vitro transformation of adult neural precursors into stem-like cancer cells. Brain Pathol. 2009; 19: 399-408.
7. Tang XQ, Heron P, Mashburn C, et al. Targeting sensory axon regeneration in adult spinal cord. J Neurosci. 2007; 27: 6068-6078.
8. Amariglio N, Hirshberg A, Scheithauer BW, et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 2009; 6: e1000029.
9. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100: 3983-3988.
10. Hemmati HD, Nakano I, Lazareff JA, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 2003; 100: 15178-15183.
11. Furnari FB, Fenton T, Bachoo RM, et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 2007; 21: 2683-2710.
12. Li X, Xu J, Bai Y, et al. Isolation and characterization of neural stem cells from human fetal striatum. Biochem Biophys Res Commun 2005; 326: 425-434.
13. Mapara KY, Stevenson CB, Thompson RC, et al. Stem cells as vehicles for the treatment of brain cancer. Neurosurg Clin N Am 2007; 18: 71-80.
14. Clarke DL, Johansson CB, Wilbertz J, et al. Generalized potential of adult neural stem cells. Science 2000; 288: 1660-1663.
15. Bjorklund A, Lindvall O. Cell replacement therapies for central nervous system disorders. Nat Neurosci 2000; 3: 537-544.
16. Horner PJ, Gage FH. Regenerating the damaged central nervous system. Nature 2000; 407: 963-970.
17. Lagasse E. Cancer stem cells with genetic instability: the best vehicle with the best engine for cancer. Gene Ther. 2008; 15: 136-142.
18. Kelly S, Bliss TM, Shah AK, et al. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci U S A 2004; 101: 11839-11844.
19. Micallef J, Taccone M, Mukherjee J, et al. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression. Cancer Res 2009; 69: 7548-7556.
20. Maher EA, Furnari FB, Bachoo RM, et al. Malignant glioma: genetics and biology of a grave matter. Genes Dev 2001; 15: 1311-1333.
21. Calabrese C, Poppleton H, Kocak M, et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007; 11: 69-82.
22. Gilbertson RJ, Rich JN. Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat Rev Cancer 2007; 7: 733-736.
23. Imitola J, Raddassi K, Park KI, et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A 2004; 101: 18117-18122.
24. Han Z, Ren H, Zhao H, et al. Hypoxia-inducible factor (HIF)-1{alpha} directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF). Carcinogenesis 2008; 29: 1853-1861.
25. Sun L, Hui A, Su Q, et al. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 2006; 9: 287-300.
26. Tachibana K, Hirota S, Iizasa H, et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 1998; 393: 591-594.
27. Liu Y, Ji R, Li J, et al. Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis. J Exp Clin Cancer Res 2010; 29: 16.
28. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000; 103: 211-225.
29. Burger JA, Kipps TJ: CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006; 107: 1761-1767.
30. Eck SM, Cote AL, Winkelman WD, et al. CXCR4 and matrix metalloproteinase-1 are elevated in breast carcinoma-associated fibroblasts and in normal mammary fibroblasts exposed to factors secreted by breast cancer cells. Mol Cancer Res 2009; 7: 1033-1044.
31. Porcile C, Bajetto A, Barbero S, et al. CXCR4 activation induces epidermal growth factor receptor transactivation in an ovarian cancer cell line. Ann N Y Acad Sci 2004; 1030: 162-169.
32. Schonemeier B, Schulz S, Hoellt V, et al. Enhanced expression of the CXCl12/SDF-1 chemokine receptor CXCR7 after cerebral ischemia in the rat brain. J Neuroimmunol 2008; 198: 39-45.
33. Nicholson RI, Gee JM, Harper ME. EGFR and cancer prognosis. Eur J Cancer 2001; 37 (Suppl 4): S9-15.
34. Venkatakrishnan G, Salgia R, Groopman JE. Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells. J Biol Chem 2000; 275: 6868-6875.
35. Grandal MV, Zandi R, Pedersen MW, et al. EGFRvIII escapes down-regulation due to impaired internalization and sorting to lysosomes. Carcinogenesis 2007; 28: 1408-1417.
36. Rossi G, Marchioni A, Longo L. EGFR mutations and sensitivity to gefitinib. N Engl J Med 2004; 351: 1260-1261.
37. Lee JC, Vivanco I, Beroukhim R, et al. Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain. PLoS Med 2006; 3: e485.
38. Schwechheimer K, Huang S, Cavenee WK. EGFR gene ampli-fication--rearrangement in human glioblastomas. Int J Cancer 1995; 62: 145-148.
39. Bax DA, Gaspar N, Little SE, et al. EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines. Clin Cancer Res 2009; 15: 5753-5761.
40. Inda MM, Bonavia R, Mukasa A, et al. Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cyto-kine circuit in glioblastoma. Genes Dev 2010; 24: 1731-1745.